These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12643015)

  • 1. Cancer drug development in Europe: a selection of new agents under development at the European Drug Development Network.
    Lacombe D; Butler-Smith A; Therasse P; Fumoleau P; Burtles S; Calvert H; Marsoni S; Sessa C; Verweij J
    Cancer Invest; 2003; 21(1):137-47. PubMed ID: 12643015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EORTC and drug development. European Organisation for Research and Treatment of Cancer.
    Lacombe D; Fumoleau P; Zwierzina H; Twelves C; Hakansson L; Jayson G; Lehmann F; Verweij J; ;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S19-23. PubMed ID: 11858959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EORTC Laboratory Research Division. European Organisation for Research and Treatment of Cancer.
    Brünner N; Double J; Fichtner I; Gescher A; Newell D; Oosterhuis W; Price P
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S14-8. PubMed ID: 11858958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing targeted therapies for lung cancer.
    Gandara DR
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
    [No Abstract]   [Full Text] [Related]  

  • 5. Addressing the challenge of intergroup studies in oncology: the EORTC experience. European Organisation for Research and Treatment of Cancer.
    Zurlo A; Therasse P
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S169-72. PubMed ID: 11858988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scientific review of EORTC trials: the functioning of the New Treatment Committee and Protocol Review Committee.
    Lardot C; Steward W; Van Glabbeke M; Armand JP
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S24-30. PubMed ID: 11858960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EORTC Melanoma Group: a comprehensive melanoma research programme by clinicians and scientists. European Organisation for Research and Treatment of Cancer.
    Eggermont AM; Keilholz U; Autier P; Ruiter DJ; Lehmann F; Lienard D;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S114-9. PubMed ID: 11858976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EORTC Breast Cancer Group: 40 years of research contributing to improve breast cancer management.
    Therasse P; Piccart M; van de Velde CJ; Jassem J;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S39-43. PubMed ID: 11858963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of molecularly targeted anticancer therapies: an Eli Lilly and Company perspective.
    Perry WL; Weitzman A
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):199-202, 237-8. PubMed ID: 16166991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
    Pearson ADJ; Zwaan CM; Kolb EA; Karres D; Guillot J; Kim SY; Marshall L; Tasian SK; Smith M; Cooper T; Adamson PC; Barry E; Benettaib B; Binlich F; Borgman A; Brivio E; Capdeville R; Delgado D; Faller D; Fogelstrand L; Fraenkel PG; Hasle H; Heenen D; Kaspers G; Kieran M; Klusmann JH; Lesa G; Ligas F; Mappa S; Mohamed H; Moore A; Morris J; Nottage K; Reinhardt D; Scobie N; Simko S; Winkler T; Norga K; Reaman G; Vassal G
    Eur J Cancer; 2020 Sep; 136():116-129. PubMed ID: 32688206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EORTC Brain Tumor Group: achievements and perspectives.
    Vecht ChJ; van den Bent MJ; Lacombe D
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S35-8. PubMed ID: 11858962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are targeted therapies really targeted?
    Schilsky RL
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):722-3. PubMed ID: 16258475
    [No Abstract]   [Full Text] [Related]  

  • 13. The European Organisation for Research and Treatment of Cancer strategy for new drug development in brain tumors.
    Lacombe D; Brandes AA; van den Bent M
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):77-80. PubMed ID: 14765392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EORTC Boron Neutron Capture Therapy (BNCT) Group: achievements and future projects.
    Sauerwein W; Zurlo A;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S31-4. PubMed ID: 11858961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory issues for clinical trials at EORTC: the way forward. European Organisation for Research and Treatment of Cancer.
    Baeyens AJ; Lacombe D
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S142-6. PubMed ID: 11858981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EORTC clinical research coordinators group. European Organisation for Research and Treatment of Cancer.
    Fishwick K; Berridge J; Coffey M; Colussi AM; Di Giulio P; Marinus A; Molin C; Peters M
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S54-9. PubMed ID: 11858966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EORTC Gastrointestinal Tract Cancer Group: 40 years of research contributing to improved GI cancer management.
    Anak O; Van Cutsem E; Nordlinger B
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S65-70. PubMed ID: 11858968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 40 years of the EORTC: the evolution towards a unique network to develop new standards of cancer care. European Organisation for Research and Treatment of Cancer.
    Meunier F; van Oosterom AT
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S3-13. PubMed ID: 11858957
    [No Abstract]   [Full Text] [Related]  

  • 19. [Topoisomerases I: new targets for the treatment of cancer and mechanisms of resistance].
    Pourquier P; Pommier Y
    Bull Cancer; 1998 Dec; Spec No():5-10. PubMed ID: 9932078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of novel anticancer drug targets.
    Buolamwini JK; Assefa H
    Methods Mol Med; 2003; 85():3-28. PubMed ID: 12710193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.